Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value: $1.194B (100.0% shares, 0.0% debt)

Holdings (37)

BMRN BIOMARIN PHARMACEUTICAL INC 10.9%
Value $130M Shares 1,544,163 Share Price $84.50 Est. Cost/Share $80.19 Unrealized @ Report Date +7.5%
STAA STAAR SURGICAL CO 8.9%
Value $106M Shares 3,278,523 Share Price $32.26 * Est. Cost/Share $13.06 Unrealized @ Report Date +158.0%
INSM INSMED INC 8.1%
Value $97.07M Shares 6,055,623 Share Price $16.03 * Est. Cost/Share $17.16 Unrealized @ Report Date +38.1%
— EPIZYME INC 7.2%
Value $86.11M Shares 5,551,803 Share Price $15.51 Est. Cost/Share $15.12 Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP 7.0%
Value $83.12M Shares 876,575 Share Price $94.82 Est. Cost/Share $88.73 Unrealized @ Report Date +7.1%
— KARYOPHARM THERAPEUTICS INC 6.9%
Value $82.6M Shares 4,299,901 Share Price $19.21 Est. Cost/Share $17.42 Unrealized @ Report Date —
— ABIOMED INC 6.1%
Value $72.98M Shares 502,745 Share Price $145.16 Est. Cost/Share $37.80 Unrealized @ Report Date —
— IMMUNOMEDICS INC 6.0%
Value $71.32M Shares 5,290,746 Share Price $13.48 Est. Cost/Share $13.38 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 5.8%
Value $68.93M Shares 1,631,524 Share Price $42.25 * Est. Cost/Share $27.34 Unrealized @ Report Date +50.7%
FOLD AMICUS THERAPEUTICS INC 5.8%
Value $68.82M Shares 7,447,618 Share Price $9.24 * Est. Cost/Share $7.59 Unrealized @ Report Date +25.2%
— ALEXION PHARMACEUTICALS INC 4.8%
Value $57.69M Shares 642,491 Share Price $89.79 Est. Cost/Share $121.54 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 4.0%
Value $47.52M Shares 3,295,712 Share Price $14.42 Est. Cost/Share $22.84 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 3.6%
Value $42.84M Shares 4,134,846 Share Price $10.36 * Est. Cost/Share $11.21 Unrealized @ Report Date +10.6%
— MOMENTA PHARMACEUTICALS INC 3.5%
Value $41.56M Shares 1,527,956 Share Price $27.20 Est. Cost/Share $14.06 Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 2.5%
Value $29.48M Shares 4,635,789 Share Price $6.36 Est. Cost/Share $48.59 Unrealized @ Report Date —
— AMAG PHARMACEUTICALS INC 1.6%
Value $18.56M Shares 3,002,748 Share Price $6.18 Est. Cost/Share $29.07 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 1.4%
Value $16.85M Shares 586,674 Share Price $28.72 Est. Cost/Share $48.62 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 1.1%
Value $13.26M Shares 76,205 Share Price $173.95 * Est. Cost/Share $114.31 Unrealized @ Report Date +109.5%
PBYI PUMA BIOTECHNOLOGY INC 1.0%
Value $11.78M Shares 1,396,163 Share Price $8.44 * Est. Cost/Share $28.26 Unrealized @ Report Date -65.6%
— REVANCE THERAPEUTICS INC 0.8%
Value $9.112M Shares 615,705 Share Price $14.80 Est. Cost/Share $15.01 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 0.7%
Value $8.296M Shares 775,296 Share Price $10.70 * Est. Cost/Share $32.98 Unrealized @ Report Date -63.3%
— WRIGHT MEDICAL GROUP NV 0.6%
Value $6.96M Shares 242,940 Share Price $28.65 Est. Cost/Share $23.42 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.5%
Value $6.095M Shares 331,813 Share Price $18.37 Est. Cost/Share $5.39 Unrealized @ Report Date —
— RIGEL PHARMACEUTICALS INC 0.5%
Value $5.526M Shares 3,542,551 Share Price $1.56 Est. Cost/Share $3.40 Unrealized @ Report Date —
KLDO KALEIDO BIOSCIENCES INC 0.4%
Value $4.846M Shares 787,999 Share Price $6.15 * Est. Cost/Share $13.76 Unrealized @ Report Date -52.6%
CYTK CYTOKINETICS INC 0.1%
Value $1.458M Shares 123,686 Share Price $11.79 * Est. Cost/Share $6.71 Unrealized @ Report Date +90.0%
— ALIMERA SCIENCES INC 0.1%
Value $804K Shares 200,919 Share Price $4.00 Est. Cost/Share $4.88 Unrealized @ Report Date —
— ZOGENIX INC 0.1%
Value $730K Shares 29,500 Share Price $24.75 Est. Cost/Share $13.36 Unrealized @ Report Date —
SNDX SYNDAX PHARMACEUTICALS INC 0.1%
Value $725K Shares 66,100 Share Price $10.97 * Est. Cost/Share $9.38 Unrealized @ Report Date 0.0%
— RETROPHIN INC 0.1%
Value $686K Shares 47,000 Share Price $14.60 Est. Cost/Share $14.60 Unrealized @ Report Date —
— INTRA-CELLULAR THERAPIES INC 0.0%
Value $575K Shares 37,400 Share Price $15.37 Est. Cost/Share $34.30 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.0%
Value $482K Shares 1,162,473 Share Price $0.41 Est. Cost/Share $4.37 Unrealized @ Report Date —
URGN UROGEN PHARMA LTD 0.0%
Value $437K Shares 24,500 Share Price $17.84 * Est. Cost/Share $27.01 Unrealized @ Report Date 0.0%
— MARINUS PHARMACEUTICALS INC 0.0%
Value $254K Shares 125,321 Share Price $2.03 Est. Cost/Share $4.17 Unrealized @ Report Date —
— MINERVA NEUROSCIENCES INC 0.0%
Value $219K Shares 36,319 Share Price $6.03 Est. Cost/Share $5.62 Unrealized @ Report Date —
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value $182K Shares 73,500 Share Price $2.48 * Est. Cost/Share $7.53 Unrealized @ Report Date -40.2%
— IDERA PHARMACEUTICALS INC 0.0%
Value $102K Shares 77,044 Share Price $1.32 Est. Cost/Share $8.90 Unrealized @ Report Date —